[UPDATED] Humana to Sell 60% of Kindred at Home Hospice to CDR for $2.8B
Hospice News
APRIL 21, 2022
Humana Inc. (NYSE: HUM) has signed a definitive agreement to sell a 60% stake in Kindred at Home’s (KAH) hospice and personal care business to the private equity firm Clayton, Dubilier & Rice (CDR) for $2.8 billion. Humana will retain the remaining 40%. Kindred at Home has been on a circuitous journey with Humana. The insurance giant acquired 40% ownership of the home health, hospice and personal care provider in 2018, with the private equity firms Welsh, Carson, Anderson & Stowe (WCAS)
Let's personalize your content